Cisplatin and Carboplatin Shortage in India 2026: A Guide for Patients and Caregivers

18 Jun 2026

9 Min. Read

Last updated on 18 Jun 2026

If you or someone in your family is undergoing chemotherapy for cancer, the news about a Cisplatin and Carboplatin shortage in India 2026 may have already reached you at a pharmacy counter, in a hospital corridor, or through a worried phone call from your oncologist. This guide is written for you. Not in medical jargon. Not in policy language. But in plain terms that explain what is happening, why it is happening, what your options are, and what to do if your treatment schedule has been disrupted.

Key Takeaways

Cisplatin and Carboplatin, two of India's most widely used chemotherapy drugs, are facing an acute nationwide shortage as of June 2026.
The shortage is driven by rising global platinum prices, limited raw material availability, and price-control constraints on domestic manufacturers.
Both drugs are life-saving cancer drugs listed on India's National List of Essential Medicines (NLEM) and are used in platinum-based chemotherapy for lung, ovarian, head and neck, bladder, and cervical cancers.
The Government of India has approved an emergency price revision to encourage manufacturers to resume full-scale production.
Oncologists have limited alternatives, and substitutes are not always equally effective or well-tolerated.
A short delay in chemotherapy, while stressful, may not always worsen outcomes, but only your oncologist can advise what is safe for your specific cancer and stage.

What Is Platinum-Based Chemotherapy?

Platinum-based chemotherapy drugs are a class of anti-cancer medicines that use platinum compounds to damage the DNA of cancer cells, stopping them from dividing and growing. They are among the oldest and most effective chemotherapy agents in modern oncology.

The three main drugs in this class are:

Drug	Common Use	Available in India
Cisplatin	Lung, head and neck, bladder, testicular, cervical cancer	Shortage reported
Carboplatin	Ovarian, lung, cervical, endometrial cancer	Shortage reported
Oxaliplatin	Colorectal cancer	Limited availability

Nearly 70 per cent of cancer patients in India are on one of these two drugs, making them among the most important medicines in oncology today, according to Dr Vashishth Maniar, Oncologist and Founding Director of MOC Cancer Care and Research Centre.

Why Is There a Shortage of Cisplatin and Carboplatin in India?

Limited global supply of platinum-based raw materials has caused a recent shortage of several oncology treatments (e.g. Cisplatin, Carboplatin). Here’s how this situation developed:

The platinum price problem: The price of platinum, a rare metal primarily produced in South Africa and Russia, has risen sharply worldwide, driving up the cost of producing platinum-based chemotherapy drugs in India.

The price control trap: The Indian government regulates the selling prices of both Cisplatin and Carboplatin through the Drug Price Control Order (DPCO), as they are both on India's National List of Essential Medicines (NLEM). The capped prices now severely limit many manufacturers' ability to produce these products profitably, even as production costs rise.

The production halt: Production of these older injectable oncology products has been consolidated among fewer suppliers, creating a more vulnerable environment when disruptions occur in raw materials, production capacity, etc.

The government response: The Central Government has formally approved emergency price increases for both cisplatin and carboplatin, but to date, no such increases have been implemented. Shortages have caused critical disruptions to patient care across many of India's leading oncology treatment facilities (e.g., AIIMS, Tata Memorial Centre).

Cisplatin vs Carboplatin: What Is the Difference?

Patients are often prescribed one or the other depending on their cancer type, kidney function, and treatment protocol. Here is a plain-language comparison:

Feature	Cisplatin	Carboplatin
Primary cancers treated	Head and neck, lung, bladder, testicular, cervical	Ovarian, lung, cervical, endometrial
Administration	Intravenous (IV), usually once every 3-4 weeks	Intravenous (IV), once every 3-4 weeks
Main side effects	Nausea, kidney toxicity, hearing loss, nerve damage	Lower kidney toxicity, more bone marrow suppression
Cisplatin vs Carboplatin side effects	More severe nausea; harder on kidneys	Easier on kidneys; causes more blood count drops
Interchangeable?	Not always depend on the cancer type and protocol	Not always your oncologist decide

The carboplatin injection price in India under regulated pricing was previously kept low, a fact that paradoxically contributed to the supply crisis by squeezing manufacturer margins.

What Are the Alternatives? Can You Switch?

This is the question most patients and caregivers are asking. The honest answer is: sometimes yes, but not always and only your oncologist should make this call.

Possible Alternatives By Cancer Type

Cancer Type	Platinum Drug Used	Possible Alternative
Lung cancer	Cisplatin or Carboplatin + another agent	Pemetrexed-based regimens (non-platinum); immunotherapy (if eligible)
Head and neck cancer	Cisplatin	Cetuximab a targeted antibody therapy. However, cost of Cetuximab vs Cisplatin for head and neck cancer is significantly higher; Cetuximab is not always covered by insurance
Ovarian cancer	Carboplatin + Paclitaxel	Cisplatin + Paclitaxel (if Carboplatin unavailable); Docetaxel combinations
Colorectal cancer	Oxaliplatin	Oxaliplatin vs Cisplatin for colorectal cancer. Oxaliplatin is actually the preferred agent here; Cisplatin is rarely used for colorectal cancer
Cervical cancer	Cisplatin	Carboplatin (under oncologist's guidance)

There are few alternatives to platinum-based cancer drugs, and substitutes can be less effective or more toxic, said oncologist Dr Venkateshwar Rao at Omega Hospital in Hyderabad. Do not switch medicines without direct guidance from your treating doctor.

What to Do If Your Chemotherapy Is Delayed

Finding out that your cisplatin 50mg injection availability or your carboplatin injection is not available at your hospital pharmacy is frightening. Here is a practical, step-by-step guide for patients and caregivers:

Step 1: Contact your oncologist immediately. Call your oncologist straight away. Your doctor needs to know about the supply problem and will be able to advise you whether to wait, switch to another medication or change the dose.
Step 2: Ask your hospital's pharmacy team. If your oncologist does not have a solution, speak to the hospital's pharmacy team. Large cancer hospitals, such as Tata Memorial, AIIMS, Apollo, and Fortis, may have their own procurement channels and may have stock even when local pharmacies do not.
Step 3: Check verified online platforms. Platforms like MrMed source medicines directly from licensed distributors and may have stock of carboplatin injection or cisplatin when local pharmacies are out. You can also buy carboplatin 450mg online India through verified platforms with a valid prescription.
Step 4: Register your need. Make sure to register your need. Some hospitals keep a waiting list for patients who require critical medications. Ensure that your treating team formally registers your need.
Step 5: Explore government cancer centres. Look at the Government Cancer Centre's stocks. AIIMS, Regional Cancer Centres and ESIC hospitals may have government-procured medications through centralised purchasing.

Is a Delay in Chemotherapy Dangerous?

This is what really keeps patients and families awake at night. Nuance and context are very, very important.

For ovarian cancer: A 2024 study found a total of 1,517 women suffering from ovarian cancer of late-stage within a population-based control trial, that inter-cycle treatment delays are not moderately associated to worsen survival outcome in patients with advanced stage ovarian cancer, albeit every case varied significantly. The effects of missing carboplatin cycle for ovarian cancer depend on what stage you are at and what your last cycle response looked like.

For lung cancer: Another meta-analysis that examined treatment delays of 4, 8, and 12 weeks in lung cancer patients found no detectable impact on short-term survival, but stressed that this does not mean one should take delays lightly. The simple answer is that there is no singularity against which to assess the question of whether a 3-week delay in chemotherapy is dangerous for lung cancer-type. Instead, it is complex because it really depends on cancer type, stage, and whether you are in the middle of a curative or palliative protocol.

The straight answer: A brief and unavoidable delay because of a chemotherapy drug shortage doesn't lead to abandonment of treatment. Your oncologist knows your case. It's time to ask your specialist.

Can You Import These Medicines?

When an Indian company cannot supply a specific cancer treatment drug, they can import either the medicine alone or the entire treatment (for example, chemotherapy).

Importation of both is possible through officially licensed importers; however, even if you obtain your medication from India, it will cost considerably more than if purchased domestically.

Consequently, any physician or pharmacist can recommend this as a treatment option. Check with your doctor to see what they believe would be best for you, and, likewise, with your pharmacist.

FAQs

Q1. Why is there a shortage of Cisplatin in India in 2026?

Platinum prices are soaring worldwide, driving up manufacturing costs. The price of the drug, which is set by the government, has caused many manufacturers to stop production. Because the government just approved a price increase, manufacturers can now return to the market with a better supply of drugs.

Q2. Can Carboplatin be used instead of Cisplatin?

Sometimes you can adjust medications based on what type of cancer you have and what treatment protocol you are following. You cannot make these adjustments on your own; only your oncologist can help with this.

Q3. How long can you delay Cisplatin chemotherapy safely?

There is no fixed answer for how long a delay in receiving a medication will be acceptable. A delay of a few weeks (2 weeks or less) is typically acceptable, but this depends on the type of cancer, how far along it is, and the overall goal of treatment. If there is a delay in receiving a particular medication, you should contact your oncologist right away.

Q4. Where can I buy Carboplatin or Cisplatin if it is out of stock locally?

The first place you should check is your hospital pharmacist. Many government-run cancer treatment centres have access to medications through central purchasing. Additional resources that may offer medications with licensed prescriptions include licensed medical websites, such as MrMed, that sell medicine.

Q5. Are there alternatives to Cisplatin for lung cancer?

In some cases, yes; particularly if your treatment is non-platinum based or if you are using a non-platinum based regimen but using immunotherapy as part of your treatment. Each type of treatment should be determined by your oncologist before you receive treatment.

Final Thoughts

A shortage of chemotherapy medicines is not just a supply-chain story; it is a human story. Behind every vial that is unavailable is a patient sitting in a hospital chair, a caregiver making frantic calls to pharmacies, and a family trying to hold itself together.

The Cisplatin and Carboplatin shortage in India 2026 is serious, but it is being addressed. The government's emergency price intervention is a step in the right direction. In the meantime, if your treatment has been disrupted, keep your oncologist in the loop, explore verified sourcing options, and do not make any medication decisions without medical guidance.

References

Business Today [Internet]. Mumbai: Business Today; 2026 Jun 05 [cited 2026 Jun 11]. Behind the cancer drug shortage: why Indian oncology wards are facing an uphill task. Available from: https://www.businesstoday.in/latest/corporate/story/behind-the-cancer-drug-shortage-why-indian-oncology-wards-are-facing-an-uphill-task-535188-2026-06-05
Roy S. Medical Dialogues [Internet]. New Delhi: Medical Dialogues; 2026 Jun 11 [cited 2026 Jun 11]. Centre approves price hike for Cisplatin, Carboplatin to tackle nationwide cancer drug shortage. Available from: https://medicaldialogues.in/news/industry/pharma/centre-approves-price-hike-for-cisplatin-carboplatin-to-tackle-nationwide-cancer-drug-shortage-172610
Vishwakarma S. Free Press Journal [Internet]. Mumbai: FPJ; 2026 Jun 10 [cited 2026 Jun 11]. How supply chain constraints have made chemotherapy drugs Cisplatin and Carboplatin costlier. Available from: https://www.freepressjournal.in/india/how-supply-chains-constraints-have-made-chemotherapy-drugs-cisplatin-and-carboplatin-costlier

Disclaimer: This article is for general informational purposes only. It does not constitute medical advice. If your chemotherapy schedule has been disrupted, contact your oncologist immediately. Do not substitute, delay, or alter your treatment without direct medical guidance.